Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) saw a significant growth in short interest in November. As of November 30th, there was short interest totalling 1,200 shares, a growth of 140.0% from the November 15th total of 500 shares. Based on an average daily volume of 6,500 shares, the short-interest ratio is currently 0.2 days.

Relief Therapeutics Stock Performance

Shares of Relief Therapeutics stock traded down $0.12 during midday trading on Thursday, hitting $4.25. The company’s stock had a trading volume of 967 shares, compared to its average volume of 2,895. The stock has a 50-day simple moving average of $5.88 and a 200-day simple moving average of $3.12. Relief Therapeutics has a 1-year low of $1.10 and a 1-year high of $7.66.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.